Ossianix receives milestone payment from Lundbeck for blood-brain barrier (BBB) antibody delivery technology

By WebmasterJanuary 25, 2017November 1st, 2024No Comments

Ossianix receives milestone payment from Lundbeck for blood-brain barrier (BBB) antibody delivery technology

Previous PostImmigrant-founded Keriton raised $1 million to help keep premature babies on breast milk
Next PostRelmada Announces FDA Acceptance of IND and Authorization to Commence Phase 2a Clinical Trial for d-Methadone